Although mutations in additional genes (such as PALB2, CHEK2, and ATM) and novel loci identified through genome-wide association studies (GWAS) have also been found to predispose people to breast cancer, together these alleles only confer a minor increase in risk in non-BRCA1/2 families [1-3]. The gene discussed is PALB2; the disease is breast cancer.